 | | Vol. 12.48 – 7 December, 2023 |
| |
|
|
| Scientists studied the impact of the apolipoprotein B mRNA-editing catalytic subunit-like (APOBEC) enzyme APOBEC3B on epidermal growth factor receptor-driven lung cancer.
[Nature Genetics] |
|  |
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Following intratracheal aerosol delivery of Cy5-labeled peptide in rhesus macaques, the authors confirmed delivery throughout the respiratory tract.
[Nature Communications] |
|
|
|
| K329R knockin mice with defective RBM47-ISGylation displayed heightened susceptibility to LPS-induced acute lung injury and lung tumorigenesis.
[Cell Death Discovery] |
|
|
|
| Human alveolar epithelial cells and macrophages were exposed in vitro to dust and assessed for cytotoxicity and inflammation.
[Respirology] |
|
|
|
| The angiotensin (Ang)-(1–7)-/Mas axis inhibited TGF-β1-induced lung fibroblast differentiation, inflammation, and fibrosis in bleomycin-treated lung tissue.
[European Journal Of Pharmacology] |
| |
|
|
| The authors investigated the biological effects of chemically characterized indoor dust extracts using three-dimensional lung cancer cell cultures combining phenotypic and lipidomic analyses.
[Environmental Science & Technology] |
|
|
|
| Elevated USP13 promoted KRAS-mutant NSCLC metastasis, which was associated with poor prognosis in NSCLC patients.
[Cell Reports] |
|
|
|
| The binding targets and underlying mechanisms of the differentially expressed miRNAs were verified by in vitro and in vivo experiments.
[Cell Death & Disease] |
|
|
|
| The in vitro cytotoxicity of the 17 semisynthesized derivatives of renieramycin S against human NSCLC cells in parallel with normal cell lines was evaluated.
[Scientific Reports] |
|  |
|
|
|
| The roles and importance of extracellular vesicles substantially differs between studies, depending on experimental conditions and parent cell origins of extracellular vesicles that modify the nature of their cargo.
[Journal Of Nanobiotechnology] |
|
|
|
|
| The therapy is a bispecific antibody targeting EGFR and c-MET, which are believed to be dysregulated in many tumors such as NSCLC.
[Fierce Biotech] |
|
|
|
|
| January 22 – 25, 2024
Santa Fe, New Mexico, United States |
|
|
|
|
|
| | Cedars-Sinai – Los Angeles, California, United States |
|
|
|
| | University of California, San Francisco – San Francisco, California, United States |
|
|
|
| | Indiana University – Indiana, Pennsylvania, United States |
|
|
|
| | Rutgers Health – Newark, New Jersey, United States |
|
|
|
| | Royal College of Surgeons in Ireland – Dulin, Ireland |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
